Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Verismo Therapeutics
Nurix Therapeutics, Inc.
Context Therapeutics Inc.
Numab Therapeutics AG
Ascentage Pharma Group Inc.
University of Pennsylvania
Checkpoint Therapeutics, Inc.
UTC Therapeutics Inc.
Prelude Therapeutics
Centre Hospitalier Universitaire Vaudois
Multitude Therapeutics Inc.
Quadriga Biosciences, Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Abramson Cancer Center at Penn Medicine
Chinese PLA General Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)